Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.

Colditz, Graham A

Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin. [electronic resource] - Breast cancer research : BCR 2007 - 108 p. digital

Publication Type: Comment; Editorial; Research Support, Non-U.S. Gov't

1465-542X

10.1186/bcr1736 doi


Breast Neoplasms--epidemiology
Drug Therapy, Combination
Estrogen Replacement Therapy--adverse effects
Estrogens--adverse effects
Female
Humans
Progestins--adverse effects